Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens

Clinical Transplantation

Volumn 27, Issue 2, 2013, Pages 319-323

  Kanzelmeyer, Nele K ^a   Ahlenstiel, Thurid ^a   Kreuzer, Martin ^a   Becker, Jan U ^a   Pape, Lars ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Banff classification; Children; Glomerular filtration rate; Kidney; Kidney transplantation; Pediatric; Protocol biopsy; Renal transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; ATROPHY; CHILD; CLINICAL PROTOCOL; COLD ISCHEMIA; CORRELATION ANALYSIS; FEMALE; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84876071079     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12092     Document Type: Article

References (18)

1. Weir MR, Wali RK. Minimizing the risk of chronic allograft nephropathy. Transplantation 2009: 87: 14.
2. Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int 2002: 62: 704.
3. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326.
4. Van Besouw NM, Van De Wetering J, Van Der Mast BJ, de Kuiper R, Baan CC, Weimar W. After discontinuation of calcineurin inhibitars, tapering of mycophenalate mofetil further impairs donor-directed cytotoxicity. Clin Transplant 2008: 22: 129.
5. Bresnahan BA, Johnson CP, McIntosh MJ, Stablein D, Hariharan S. A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor. Am J Transplant 2002: 2: 366.
6. Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000: 343: 1078.
7. Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000: 69: 1414.
8. Vats A, Gillingham K, Matas A, Chavers B. Improved late graft survival and half-lives in pediatric kidney transplantation: a single center experience. Am J Transplant 2002: 2: 939.
9. Nunes P, Parada B, Pratas J et al. Cadaveric donor factor variations during a 12-year period: influence on kidney transplant outcomes. Transplant Proc 2006: 38: 1867.
10. Hernández D, Estupinán S, Pérez G et al. Impact of cold ischemia time on renal allograft outcome using kidneys from young donors. Transpl Int 2008: 21: 955.
11. Opelz G, Döhler B. Multicenter analysis of kidney preservation. Transplantation 2007: 83: 247.
12. Pape L, Offner G, Kreuzer M et al. De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation. Am J Transplant 2010: 10: 2349.
13. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008: 8: 753.
14. Schwartz GJ, Munoz A, Schneider MF et al. New equations to GFR in children with CKD. J Am Soc Nephrol 2009: 20: 629.
15. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004: 351: 2715.
16. Ekberg H, Tedesko-Siva H, Demibas A et al. HALLORAN PF; ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007: 357: 2562.
17. Pape L, Ahlenstiel T, Ehrich JH, Offner G. Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low-dose cyclosporine A. Pediatr Transplant 2007: 11: 291.
18. Lehmkuhl HB, Mai D, Dandl M et al. Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients. J Heart Lung Transplant 2007: 26: 700.